多发性硬化症中的抗CD20单克隆抗体:重新思考当前的治疗策略
1Department of Neurology, CRC-SEP, CHU of Toulouse, Toulouse, France; University Toulouse III, Inserm UMR1291, CHU Purpan, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY), 59000 Toulouse, France.
Revue neurologique
|April 10, 2024
概括
反CD20单克隆抗体对多发性硬化症 (MS) 有效,但会导致免疫抑制. 通过延长剂量间隔重新适应这些疗法可能会降低风险,但需要进一步研究.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 反CD20单克隆抗体是多发性硬化症 (MS) 的关键B细胞耗尽疗法.
- 这些治疗方法显著影响了MS的病理生理学和疾病过程.
- 目前的局限性包括免疫抑制,感染风险,疫苗反应减弱和低血糖球蛋白血症.
研究的目的:
- 对多发性硬化症的可用的抗CD20疗法进行审查.
- 探索量身定制的剂量策略的潜力.
- 评估改变剂量对治疗相关风险的影响.
主要方法:
- 对MS中抗CD20疗法的当前文献的综述.
- 对延长剂量间隔的数据进行分析.
- 评估与免疫抑制和低甘球蛋白血症相关的风险.
主要成果:
- 延长剂量间隔在维持炎症性MS控制方面表现有前途.
- 量身定制的CD20疗法对降低低血糖和感染的影响仍在调查中.
- 令人鼓舞的数据表明,优化抗CD20疗法方案的潜在好处.
结论:
- 定制抗CD20单克隆抗体疗法是MS治疗的潜在下一步.
- 需要进一步的研究来证实修改剂量对减少不良结果的益处.
- 优化治疗策略可能会减轻长期免疫抑制风险.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
161
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
161
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K